MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Institutional Ownership and Insiders Activity
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) is widely held by institutional investors, with 168 firms reporting positions valued at approximately $1.43B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Bvf Inc/Il is the largest disclosed holder, reporting approximately $311.54M in MLTX holdings in its latest filing.
Recent insider activity includes 7 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
168
Total Reported Value
$1.43B
Largest Holder
Bvf Inc/Il
Largest Position
$311.54M
Insider Transactions (90d)
7
Latest Filing Quarter
Q2 2026
New Institutional Positions
41
Funds Exiting Positions
18
Top Institutional Owners
View allInvestorReported Balance
- Bvf Inc/Il$311.54M
- Deep Track Capital, Lp$136.27M
- T. Rowe Price Investment Management, Inc.$83.34M
- D. E. Shaw & Co., Inc.$65.53M
- Janus Henderson Group Plc$64.30M
MLTX News
All news- Great Point Partners Llc Investment Activity in Q2 2026: Focus on Biotech and Pharma Stocks
Aug 19, 2026 · valut.ai
- BVF Inc IL Portfolio Activity in Q2 2026
Aug 18, 2026 · valut.ai
Related MLTX Institutional Insights:
- MLTX 13F Institutional Holders
- MLTX Top Institutional Shareholders
- MLTX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- MLTX Insider Trading & SEC Form 4 Activity
- MLTX Articles
- Top Institutional Investor Stock Rankings